Anti-NEK2 monoclonal antibody

Pre-made anti-NEK2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NEK2/NEK2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T49102-Ab-1/ GM-Tg-hg-T49102-Ab-2Anti-Human NEK2 monoclonal antibodyHuman
GM-Tg-rg-T49102-Ab-1/ GM-Tg-rg-T49102-Ab-2Anti-Rat NEK2 monoclonal antibodyRat
GM-Tg-mg-T49102-Ab-1/ GM-Tg-mg-T49102-Ab-2Anti-Mouse NEK2 monoclonal antibodyMouse
GM-Tg-cynog-T49102-Ab-1/ GM-Tg-cynog-T49102-Ab-2Anti-Cynomolgus/ Rhesus macaque NEK2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T49102-Ab-1/ GM-Tg-felg-T49102-Ab-2Anti-Feline NEK2 monoclonal antibodyFeline
GM-Tg-cang-T49102-Ab-1/ GM-Tg-cang-T49102-Ab-2Anti-Canine NEK2 monoclonal antibodyCanine
GM-Tg-bovg-T49102-Ab-1/ GM-Tg-bovg-T49102-Ab-2Anti-Bovine NEK2 monoclonal antibodyBovine
GM-Tg-equg-T49102-Ab-1/ GM-Tg-equg-T49102-Ab-2Anti-Equine NEK2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T49102-Ab-1/ GM-Tg-hg-T49102-Ab-2; GM-Tg-rg-T49102-Ab-1/ GM-Tg-rg-T49102-Ab-2;
GM-Tg-mg-T49102-Ab-1/ GM-Tg-mg-T49102-Ab-2; GM-Tg-cynog-T49102-Ab-1/ GM-Tg-cynog-T49102-Ab-2;
GM-Tg-felg-T49102-Ab-1/ GM-Tg-felg-T49102-Ab-2; GM-Tg-cang-T49102-Ab-1/ GM-Tg-cang-T49102-Ab-2;
GM-Tg-bovg-T49102-Ab-1/ GM-Tg-bovg-T49102-Ab-2; GM-Tg-equg-T49102-Ab-1/ GM-Tg-equg-T49102-Ab-2
Products NameAnti-NEK2 monoclonal antibody
Formatmab
Target NameNEK2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NEK2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T49102-Ag-1Recombinant multi-species NEK2/ HsPK21A/ NLK1 protein
    ORF Viral VectorvGMLP001403human NEK2 Lentivirus particle
    ORF Viral VectorpGMLP001403human NEK2 Lentivirus plasmid
    ORF Viral VectorpGMLPm001689mouse Nek2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001689mouse Nek2 Lentivirus particle


    Target information

    Target IDGM-T49102
    Target NameNEK2
    Gene ID4751,18005,114482,711473,480021,101085774,523998,100054759
    Gene Symbol and SynonymsHsPK21,NEK2,NEK2A,NLK1,PPP1R111,RP67
    Uniprot AccessionP51955
    Uniprot Entry NameNEK2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000117650
    Target ClassificationKinase

    The target: NEK2, gene name: NEK2, also named as HsPK21A, NLK1, PPP1R111, RP67, NEK2. This gene encodes a serine/threonine-protein kinase that is involved in mitotic regulation. This protein is localized to the centrosome, and undetectable during G1 phase, but accumulates progressively throughout the S phase, reaching maximal levels in late G2 phase. Alternatively spliced transcript variants encoding different isoforms with distinct C-termini have been noted for this gene. [provided by RefSeq, Feb 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.